secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioAtla, Inc. (BCAB)
CIK:        0001826892
Form:       8-K
Filed at:   2023-02-15T23:59:59+00:00
Accession:  0000950170-23-002910
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

BioAtla awards 2022 cash bonuses to executives, approves 2023 Bonus Plan
------------------------------------------------------------------------

- CEO Jay Short awarded $370,429 cash bonus for 2022, reflecting 90% of target.
- CFO Richard Waldron received $163,116; CMO Eric Sievers $160,618; President Scott Smith $257,522; SVP Finance Vasquez $90,345.
- Christian Vasquez promoted to SVP of Finance; target bonus increased from 30% to 35% of salary.
- 2023 Bonus Plan ties executive bonuses to clinical milestones (45%), R&D (20%), strategic (20%), brand (15%).
- Payouts range from 50% to 125% of target; threshold is 50% weighted performance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1826892/000095017023002910/0000950170-23-002910-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1826892/000095017023002910/bcab-20230209.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-002910

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer